A Controlled Study on Comparing Differences in CT Perfusion Imaging between Rabbits inoculated with VX2 Lung Tumor and Patients with Squamous Cell Carcinoma of the Lung

oleh: Ming-min ZHANG, Zhao-xin LIU, Qi-bao SHI, Qiang ZHANG

Format: Article
Diterbitkan: China Anti-Cancer Association 2010-12-01

Deskripsi

OBJECTIVE By analysis and evaluation of the perfusion images and perfusion parameters of the rabbits with VX2 lung tumor, the association between the perfusion parameters and tumor angiogenesis of patients with squamous cell carcinoma of the lung has been studied in order to establish a non-invasive and effective way to detect tumor blood supply, which is be able to exhibit hemodynamic data in tumors during cancer treatments.METHODS Fifteen Netherlands rabbits inoculated with VX2 lung tumor (rabbit group) and 25 patients with squamous cell carcinoma of the lung (patient group) received a multi-slice spiral CT perfusion imaging test using the Netherlands HILIPS Brilliance 16-slice spiral CT and a U.S. MEDRAD binocular high-pressure syringe. Image postprocessing was done using the special perfusion software and EBW 4.0 Workstation. Perfusion volume (PV), peak enhanced increment (PEI), transit time peak (TTP), and blood volume (BV) were measured and analyzed. RESULTS In the rabbit group, the values of the PV, PEI, TTP, and BV of the tumor margin were (53.89 ± 13.38) mL/(min*mL), (45.71 ± 15.52) Hu, (39.29 ± 10.10) sec, and (31.45 ± 18.19) mL/100 g, respectively; these values of the tumor center were (36.57 ± 14.17) mL/(min*mL), (28.64 ± 11.74) Hu, (39.00 ± 9.78) sec, and (19.76± 13.95) mL/100 g, respectively; the values of the muscles were (12.45 ± 4.38) mL/(min*mL), (10.98 ± 5.03) Hu, (38.86 ± 10.04) sec, and (5.38 ± 2.87) mL/100 g, respectively. The values of the relative perfusion volume (RPV), relative peak enhanced increment (RPEI), and relative blood volume (RBV) of the tumor margin were 4.38 ± 1.45, 3.96 ± 1.45, 9.99 ± 11.7, respectively; these values of the tumor center were 2.14 ± 1.08, 1.83 ± 1.45, 4.17 ± 3.39, respectively. The values of the PV, PEI, BV of the tumor margin vs. the values of the muscles developed t-values, which were 15.028, 10.79, and 5.88, respectively (P ≤ 0.01), with statistical significance; the values of the PV, PEI, BV of the tumor center vs. the values of the muscles produced t-values, which were 8.67, 7.49, and 4.55, respectively (P ≤ 0.01), with statistical signifi cance. The values of the TTP of the tumor margin vs. TTP values of the muscles, and the TTP values of the tumor center vs. TTP values of the muscles developed t-values, which were 1.7 and 0.806, respectively (P ≥ 0.05), without statistical significance. In the patient group, the values of the PV, PE, TTP, and BV of the tumor margin were (88.95 ± 30.89) mL/(min*mL), (61.87 ± 27.31) Hu, (37.72 ± 12.53) sec, and (18.38 ± 7.2) mL/100 g, respectively; these values of the tumor center were (39.77 ± 18.29) mL/(min*mL), (14.57 ± 8.1) Hu, (35.64 ± 12.41) sec, and (11.22 ± 6.02) mL/100 g, respectively; these values of the muscles were (12.45 ± 6.5) mL/(min*mL), (6.14 ± 2.66) Hu, (35.68 ± 12.35) sec, and (2.23 ± 1.11) mL/100 g, respectively. The values of the RPV, RPEI, and RBV of the tumor margin were 8.05 ± 5.04, 8.87 ± 4.32, and 12.16 ± 8.49, respectively; these values of the tumor center were 2.39 ± 1.68, 2.97 ± 2.1, 3.53 ± 2.82, respectively. The values of the PV, PEI, BV of the tumor margin in the patient group vs. the values of the muscles produced t-values, which were 13.8, 10.85, and 12.22, respectively (P <0.01), with signifi cant di? erences; these values of the tumor center vs. the values of the muscles developed t-values, which were 9.158, 6.26, 8.654, respectively (P < 0.01), with signifi cant di? erences. The TTP value of the tumor margin vs. that of the muscles produced t-value, which was 0.371, and the TTP value of the tumor center vs. that of the muscles developed t-value, which was 1 (P > 0.05), without statistical di? erence. CONCLUSION CT perfusion imaging technics demonstrates directly dynamic changes of blood fl ow to tumors, which assists in identifying tumor growth and necrosis, therefore, this research provides an evidence-based guidelines for the treatment of human lung squamous cell carcinoma and has far-reaching clinical signifi cancer.